U of M celebrates the opening of the “Gateway to the Biomedical Discovery District”

Friday, June 14, 2013

The University of Minnesota celebrated the opening of the “gateway to the Biomedical Discovery District,” the new Cancer and Cardiovascular Research Building (CCRB), earlier today.

Biomedical Discovery districtThe CCRB is the fifth addition to the University’s Biomedical Discovery District, a complex of the most advanced research buildings found anywhere in the state. The facility joins the Lions Research Building, the McGuire Translational Research Facility, the Winston and Maxine Wallin Medical Biosciences Building and the Center for Magnetic Resonance Research.

In the coming weeks, the Lillehei Heart Institute and the Department of Integrative Biology and Physiology will relocate 20-25 investigators to the new facility to continue their work in cardiac regeneration, cardiac development, muscular dystrophy, congenital heart medicine and genomics. Going forward, the groups plan to add nearly four investigators per year to the new building.

The Masonic Cancer Center plans to utilize the new space for two specific groups of investigators: chemical biologists focusing on studying chemical carcinogens as a cause of cancer, and faculty focusing on novel new therapeutic strategies to fight cancer.

In partnership with the state of Minnesota, the University of Minnesota developed the Biomedical Discovery district to allow researchers from across the Academic Health Center to work side by side, unlocking new cures and therapies for our most challenging health conditions.

As an incubator for new ideas and products, the Biomedical Discovery District will bolster Minnesota’s economy, firmly positioning the state as a leader in the bioscience industry.

“We think of the Biomedical Discovery District as a neighborhood, full of extremely talented investigators,” said Aaron Friedman, M.D., senior vice president of the University’s health sciences and dean of the University of Minnesota Medical School. “By bringing them together – and encouraging them to collaborate – we’re facilitating new ideas and approaches to curing some of the world’s most devastating diseases.”